HMPO-DAPy is an experimental antiviral drug.[1]

HMPO-DAPy
Names
Preferred IUPAC name
[({(2R)-1-[(2,6-Diaminopyrimidin-4-yl)oxy]-3-hydroxypropan-2-yl}oxy)methyl]phosphonic acid
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
  • InChI=1S/C8H15N4O6P/c9-6-1-7(12-8(10)11-6)17-3-5(2-13)18-4-19(14,15)16/h1,5,13H,2-4H2,(H2,14,15,16)(H4,9,10,11,12)/t5-/m1/s1
    Key: SDORNFBUOMQVCA-RXMQYKEDSA-N
  • C1=C(N=C(N=C1OC[C@@H](CO)OCP(=O)(O)O)N)N
Properties
C8H15N4O6P
Molar mass 294.204 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

References

edit
  1. ^ Gammon, Don B.; Snoeck, Robert; et al. (December 2008). "Mechanism of Antiviral Drug Resistance of Vaccinia Virus: Identification of Residues in the Viral DNA Polymerase Conferring Differential Resistance to Antipoxvirus Drugs". Journal of Virology. 82 (24): 12520–12534. doi:10.1128/JVI.01528-08. PMC 2593306. PMID 18842735.
edit